News

Belite Bio to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

SAN DIEGO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused…

1 year ago

Vera Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

Received FDA Breakthrough Therapy Designation for atacicept in IgA Nephropathy (IgAN)Presented data from Phase 2b ORIGIN study at ERA24 Congress…

1 year ago

Palisade Bio Selects Dose for Upcoming Phase 1 Clinical Study of PALI-2108 for Ulcerative Colitis

– Phase 1 human clinical study of PALI-2108 for the treatment of Ulcerative Colitis (UC) on track to commence before…

1 year ago

GN further extends the ReSound Nexia family and releases updated fitting software designed for enhanced efficiency and usability

Building on the existing ReSound Nexia™ platform, the GN Group is launching its smallest wireless In-the-Canal (ITC) hearing aid in a…

1 year ago

SphingoTec Closes €5M Series C to Accelerate Market Development and Financial Growth with Innovative Biomarkers

SphingoTec GmbH has successfully secured funding to drive its global expansion, including the US market, through strategic collaborations.The investment round…

1 year ago

Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb

Key scientific achievement advances the joint neuroscience pipeline and earns a payment of US$ 25 m to Evotec to progress…

1 year ago

Kuros Biosciences Reports First Half of 2024 Results

Financial HighlightsDirect MagnetOs™ sales increased by 159% to CHF 31.6 million from CHF 12.2 million in H1 2023; this corresponds…

1 year ago

MyndTec Inc. Announces the MyndMove System’s Showcase at the Dearborn 2024 Para Dance Sport International Competition & USA Open and Celebrates the Updated Health Canada License for the MyndMove System to Treat Lower Limb

Mississauga, Ontario--(Newsfile Corp. - August 7, 2024) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging player in…

1 year ago

KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on…

1 year ago